Why Is Temodar So Hard to Find? [Explained for 2026]

If you or a loved one has been prescribed Temodar (temozolomide) for glioblastoma or anaplastic astrocytoma, you may have already discovered that filling this prescription isn't as simple as walking into your local drugstore. Temodar is a specialty chemotherapy medication — and that distinction changes everything about how, where, and when you can get it.

In this article, we break down exactly why Temodar is so hard to find, what's driving availability challenges in 2026, and what steps patients can take to secure their supply.

What Is Temodar and Why Is It a Specialty Drug?

Temodar is the brand name for temozolomide, an oral alkylating chemotherapy agent first approved by the FDA in 1999. It is primarily used to treat newly diagnosed glioblastoma multiforme (GBM) — the most aggressive type of primary brain tumor — and anaplastic astrocytoma. Because it is a cancer drug taken at home in capsule form, it falls into the "specialty medication" category.

Specialty medications are not stocked by most retail pharmacies. The doses are calculated based on a patient's body surface area (height and weight), meaning your specific strength combination — whether 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, or 250 mg capsules — may differ from the next patient's entirely. This makes it impractical for CVS, Walgreens, or Walmart to keep every possible combination on the shelf.

Why Retail Pharmacies Often Don't Stock Temodar

There are several structural reasons why standard pharmacies don't routinely carry temozolomide:

Low prescription volume: Glioblastoma affects approximately 14,000–15,000 Americans each year. Because it's a relatively rare cancer, demand for temozolomide at any single pharmacy is minimal.

High cost and insurance complexity: The retail cost of a 5-day supply of Temodar brand can exceed $3,400. Generic temozolomide can still cost $100–$600+ per cycle depending on the strength. Pharmacies must manage these costs carefully.

Specialty pharmacy routing: Most insurance plans require that cancer medications like temozolomide be dispensed through a designated specialty pharmacy or the patient's cancer center pharmacy.

IV temozolomide shortage history: The intravenous formulation of temozolomide has appeared on institutional drug shortage lists. While the oral generic is generally available from multiple manufacturers (Teva, Sun Pharma, Dr. Reddy's, Amneal), localized supply gaps can still occur.

Is There a National Temodar Shortage in 2026?

As of 2026, there is no widespread national shortage of oral generic temozolomide. Multiple generic manufacturers produce temozolomide capsules, which has stabilized the oral supply. However, the brand-name Temodar (made by Merck) is not widely stocked at retail pharmacies and is typically dispensed through oncology clinic pharmacies or specialty pharmacy networks.

The IV formulation of temozolomide (used when patients cannot swallow capsules) has experienced periodic shortages at certain hospital systems, listed in oncology pharmacy surveys. Patients receiving IV treatment should work closely with their treatment center's pharmacy to ensure supply is confirmed before each cycle.

Why Your Insurance May Be Blocking Access

Even when temozolomide is physically available, insurance hurdles can delay access significantly. Common barriers include:

Prior authorization: Most insurance plans require pre-approval for specialty chemotherapy drugs. This can take 2–5 business days or longer.

Specialty pharmacy lock-in: Your insurer may only cover temozolomide when dispensed by their preferred specialty pharmacy, which may require additional enrollment steps.

Quantity limits: Some plans limit the number of capsules dispensed per fill, which may require additional authorization for the full 5-day course.

38,717+ patients found their medications in stock

38K+

Find Temodar In Stock Today →

Where Does Temodar Actually Get Dispensed?

Most patients receive temozolomide through one of these channels:

Oncology clinic or cancer center pharmacy — the most common route during active chemoradiation

Specialty pharmacies (Accredo, CVS Specialty, Walgreens Specialty, BioPlus, etc.) — used for maintenance therapy delivered by mail or local pickup

Hospital inpatient pharmacy — for IV temozolomide during active treatment at a medical center

What Should You Do If You Can't Find Temodar?

If you're experiencing difficulty filling your temozolomide prescription, here are concrete steps to take immediately:

Call your oncologist's office right away — they often have direct connections with specialty pharmacies and can intervene on your behalf.

Ask about generic temozolomide — it is therapeutically equivalent to brand Temodar and available from multiple manufacturers.

Contact your insurer's specialty pharmacy directly — verify your prescription is routing correctly and that prior authorization has been submitted.

Use medfinder — medfinder contacts pharmacies near you on your behalf to find which ones can fill your specific prescription, saving you hours of calling around.

Skip the calls, skip the stress.

Find Temodar In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

How medfinder Can Help Temodar Patients

medfinder is a service designed specifically for patients who are struggling to locate medications at pharmacies near them. You provide your medication name, dosage, and location — and medfinder calls pharmacies in your area to check which ones can fill your prescription. Results are texted directly to you, so you don't have to spend valuable time and energy making dozens of phone calls yourself.

For more specific strategies on locating temozolomide near you, see our guide: How to Find Temodar in Stock Near You (Tools + Tips).

The Bottom Line

Temodar is hard to find at standard pharmacies primarily because it is a specialty chemotherapy drug — not a common retail medication. Supply of generic temozolomide is stable from multiple manufacturers, but insurance routing, specialty pharmacy requirements, and the sheer rarity of the diagnosis mean many patients face real hurdles. Knowing your options, acting proactively, and using resources like medfinder can make a significant difference in getting your treatment on time.